Welcome
The Wisconsin Alzheimer’s Institute is committed to health equity and to improving the quality of life of people living with Alzheimer’s disease or other dementia and their families. Through research initiatives, statewide memory clinic development, education and public health programs, we identify and provide strategies to reduce dementia risk and offer access to effective care. We invite you to join us in building a future to remember.
News
Dr. Walaszek interviewed on WPR about Alzheimer’s drug aducanumab
Art Walaszek, MD, public health leader for WAI, was a guest on WPR to discuss the Alzheimer's disease drug aducanumab and its approval by the FDA.
FDA approves aducanumab for Alzheimer’s disease treatment
On June 7, the U.S. Food and Drug Administration (FDA) approved the drug aducanumab for the treatment of Alzheimer’s disease.
WAI Regional Milwaukee office and Dr. Norris featured in MKE Lifestyle magazine
Thank you MKE Lifestyle for a feature article about WAI Regional Milwaukee Office and their work addressing Alzheimer's disease and dementia in the Milwaukee community.
- More WAI News posts